HLA-A and -B carrier frequencies of stage IV melanoma patients (739 HLA-A; 709 HLA-B) and healthy bone marrow donors (13,386) were compared using a two sided chi-square test with a 95% confidence interval and sorted according to the absolute difference. This evidence concerns the gene HLA-A and melanoma.